Publications

As studies are completed using data from either ToxIC’s main Registry, or one of its focused sub-Registries, results are often presented at national or international meetings. Presentations at meetings are usually published in the form of abstracts. Once data analysis is complete and individual study questions are answered, ToxIC investigators strive to publish their results as full length scholarly papers in peer-reviewed high quality medical and scientific journals.

Published Papers

The following list of papers have been published in medical research journals utilizing data gathered from ToxIC registry sites.

View all papers by year. Use CTRL-F (PC) or Command-F (Mac) to search publications by keyword, topic, or author.

2022

1. Baumgartner K, Doering M, Mullins ME; On behalf of the Toxicology Investigators Consortium (ToxIC). Dexmedetomidine in the treatment of toxicologic conditions: a systematic review and review of the toxicology investigators consortium database. Clin Toxicol (Phila). 2022:1-20. View Publication

2. Calello D, Aldy K, Jefri M, Nguyen TT, Krotulski A, Logan B, Brent J, Wax P, Walton S, Manini AF; On behalf of the ToxIC Fentalog Study Group. Identification of a Novel Opioid, N-piperidinyl etonitazene, in patients with suspected opioid overdose. Clin Toxicol (Phila). 2022:1-3. View Publication

3. Cohen N, Mathew M, Davis A, Brent J, Wax P, Schuh S, Freedman SB, Froberg B, Schwarz E, Canning J, Tortora L, Hoyte C, Koons AL, Burns MM, McFalls J, Wiegand TJ, Hendrickson RG, Judge B, Quang LS, Hodgman M, Chenoweth JA, Algren DA, Carey J, Caravati EM, Akpunonu P, Geib AJ, Seifert SA, Kazzi Z, Othong R, Greene SC, Holstege C, Tweet MS, Vearrier D, Pizon AF, Campleman SL, Li S, Aldy K, Finkelstein; On behalf of ToxIC Pediatric Opioid Exposure Study Group. Predictors of severe outcome following opioid intoxication in childrenClin Toxicol (Phila). 2022; 60(6):702-707. View Publication

4. Farah R, Kazzi Z, Brent J, Burkhart K, Wax P, Aldy K;  On behalf of the Toxicology Investigators Consortium FACT Study Group. Ivermectin associated adverse events in the treatment and prevention of COVID-19 reported to the FACT pharmacovigilance projectClin Toxicol (Phila). 2022; 1-5. View Publication

5. Love J, Karshenas D, Spyres M, Farrugia, LA, Kang AM, Nguyen H, Campleman S, Li S, Wax P, Brent J, Aldy K; On behalf of the Toxicology Investigators Consortium Study Group. The Toxicology Investigators Consortium Case Registry — the 2021 Annual Report. Journal of Medical Toxicology. 2022. View Publication

2021

1. Aldy K, Mustaquim D, Campleman S, Meyn A, Abston S, Krotulski A, Logan B, Gladden MR, Hughes A, Amaducci A, Shulman J, Schwarz E, Wax P, Brent J, Manini AF; On behalf of the ToxIC Fentalog Study Group. Notes from the Field: Illicit Benzodiazepines Detected in Patients Evaluated in Emergency Departments for Suspected Opioid Overdose — Four States, October 6, 2020–March 9, 2021Morbidity and Mortality Weekly Report. 2021:70(34);1177–1179. View Publication

2. Gilley M, Brent J, Calello DP, Wax P, Finkelstein Y; On behalf of Toxicology Investigators Consortium (ToxIC). Synthetic Cannabinoid Exposure in Adolescents Presenting for Emergency Care. Pediatr Emer Care. 2021;37(1):e13-e16. View Publication

3. Greene S, Ruha AM, Campleman S, Brent J, Wax P; On behalf of Toxicology Investigator’s Consortium (ToxIC). Epidemiology, clinical features, and management of the Texas Coral Snake (Micrurus tener) envenomations reported to the North American Snakebite Registry.  J Med Toxico. 2021;17(1):51-56. View Publication

4. Hughes AR, Lin A, Hendrickson RG. Clinical and patient characteristics associated with severe outcome in diphenhydramine toxicityClin Toxicol (Phila). 2021;8:1-5. View Publication

5. Rianprakaisang TN, Prather CT, Lin AL, Murray BP, Hendrickson RG; On behalf of Toxicology Investigator’s Consortium (ToxIC). Factors associated with seizure development after bupropion overdose: A review of the Toxicology Investigators Consortium. Clin Toxicology (Phila). 2021;59(12):1234-1238. doi: 10.1080/15563650.2021.1913180. View Publication

6. Spyres MB, Aldy K, Farrugia LA, Kang AM, Love JS, Campleman S, Li S, Amaducci A, Schwarz E, Wax P, Brent J; On behalf of the Toxicology Investigators Consortium Study Group. The Toxicology Investigators Consortium 2020 Annual Report. J Med Toxico. 2021;17(4):333-362. doi.org/10.1007/s13181-021-00854-3. View Publication

7. Surmaitis RM, Greenberg MR, Ebeling-Koning NE, Grenz PM, McWhirter CR, Careyva BA, Sabino JN, Cook MD, Cannon RD, Koons AL, Katz KD, Kincaid H, Laubach LT, Beauchamp GA; on behalf of the Toxicology Investigators’ Consortium (ToxIC). Characteristics of transgender patient cases managed by a toxicologist: An analysis of the Toxicology Investigator’s Consortium (ToxIC) Registry: January 2017 – June 2019. J Med Toxicol. 2021;17(1):16-26. View Publication

8. Varney SM, Wiegand TJ, Wax P, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC). Descriptive Analysis of Inpatient and Outpatient Cohorts Seeking Treatment After Prescription Opioid Misuse and Medical Toxicology Evaluation. J. Med. Toxicol. 2021; 17:378–385. View Publication

9. Weiss ST, Campleman S, Wax P , McGill W, Brent J; On behalf of The Toxicology Investigators Consortium (ToxIC). Failure of chelator-provoked urine testing results to predict heavy metal toxicity in a prospective cohort of patients referred for medical toxicology evaluation. Clinical Toxicology. 2021;60(2):191-196. doi:10.1080/15563650.2021.1941626. View Publication

2020

1. Beauchamp GA, Carey JL, Cook MD, Cannon RD, Katz KD, Yoon J, Kincaid H, Ely BJ, Pollack E, Mazzaccaro RJ, Greenberg MR; on behalf of Toxicology Investigator’s Consortium (ToxIC). Sex differences in pediatric poisonings by age group: A Toxicology Investigators Consortium (ToxIC) Analysis (2010-2016). J Med Toxico. 2020;16(4):423-443. View Publication

2. Beauchamp GA, Carey JL, Hurwitz MB, Tully BN, Cook MD, Cannon RD, Katz KD, Koons AL, Greenberg MR; on behalf of Toxicology Investigator’s Consortium (ToxIC). Sex differences in substance use and misuse: A Toxicology Investigators Consortium (ToxIC) Registry Analysis. J Subst Abuse Rehabil. 2020;11:23-31. View Publication

3. Beauchamp GA, Fishbein J, Makar GA, Pechulis RM, Cook MD, Cannon RD, Katz KD, Kincaid H, Carey JL, Greenberg M; on behalf of Toxicology Investigators Consortium (ToxIC). Sex differences in patients with suicidal intent that are managed by toxicologists. Am J Emerg Med. 2020;38(2):333-338. View Publication

4. Campleman SL, Brent J, Pizon AF, Shulman J, Wax p, Manini AF; on behalf of the Toxicology Investigator’s Consortium (ToxIC). Drug-specific risk of severe QT prolongation following acute drug overdose. Clin Toxicol (Phila). 2020;7:1-9. View Publication

5. Carreiro S, Miller S, Wang B, Wax P, Campleman S, Manini AF; on behalf of the ACMT Toxicology Investigators Consortium (ToxIC). Clinical predictors of adverse cardiovascular events for acute pediatric drug exposures. Clin Toxicol (Phila). 2020;58(3):183-189.  View Publication

6. Domanski K, Kleinschmidt KC, Greene S, Ruha AM, Berbata V, Onisko N, Campleman S, Brent J, Wax P; on behalf of the ToxIC North American Snakebite Registry Group. Cottonmouth snake bites reported to the ToxIC North American snakebite registry 2013-2017. Clin Toxicol (Phila). 2020;58(3):178-182. View Publication

7. Levine M, Ruha A, Wolk B, Caravati M, Brent J, Campleman S, Wax P; on behalf of the ToxIC North American Snakebite Study Group. When it comes to snakebites, kids are little adults: A comparison of adults and children with rattlesnake bites. J Med Toxicol. 2020;16(4):444-451. View Publication

8. Mehrpour O, Hoyte C, Amirabadizadeh A, Brent J; on behalf of the Toxicology Investigator’s Consortium (ToxIC). Clinical characteristics and time trends of hospitalized methadone exposures in the United States based on the Toxicology Investigator’s Consortium (ToxIC) Case Registry: 2010-2017. BMC Pharmacol Toxicol. 2020;21(1):53. View Publication

9. Murray B, Carpenter J, Dunkley C, Moran TP, Kierman EA, Rianprakaisang T, Alsukaiti WS, Calello DP, Kazzi Z; on behalf of the Toxicology Investigators Consortium (ToxIC). Single-agent bupropion exposures: Clinical characteristics and an atypical cause of serotonin toxicity. J Med Toxicol. 2020;16(1):12-16. View Publication

10. Spyres MB, Farrugia LA, Kang AM, Aldy K, Calello DP, Campleman SL, Li S, Beauchamp GA, Wiegand T, Wax PM, Brent J; on behalf of the Toxicology Investigators Consortium Study Group. The Toxicology Investigators Consortium Case Registry – The 2019 Annual Report. J Med Toxicol. 2020;16(4):361-387. View Publication

11. Tebo C, Mazer-Amirshahi M, Wax P, Campleman S, Boyer E, Brent J, Sheth A, Daniuaityte R, Carlson R; On behalf of the IN3 Study Group. Characterizing Trends in Synthetic Cannabinoid Receptor Agonist Use from Patient Clinical Evaluations during Medical Toxicology Consultation. Journal of Psychoactive Drugs. 2020;1-8. View Publication

2019

1. Anderson SAR, Oprescu AM, Calello DP, Monte A, Dayan PS, Hurd YL, Manini AF; on behalf of the Toxicology Investigators Consortium (ToxIC). Neuropsychiatric Sequelae in Adolescents with Acute Synthetic Cannabinoid Toxicity. Pediatrics. 2019;144(2):1-12. View Publication

2. Beauchamp GA, Amaducci A, Greenberg MR, Meyers M, Cook M, Cannon RD, Katz KD, Finkelstein Y; on behalf of the Toxicology Investigators Consortium (ToxIC). Adverse drug events and reactions managed by medical toxicologists: An analysis of the Toxicology Investigators Consortium (ToxIC) Registry, 2010-2016. J Med Toxicol. 2019;15(4):262-270. View Publication

3. Desai NM, Mistry RD, Brou L, Boehnke ME, Lee JS, Wang GS; on behalf of the Toxicology Investigators Consortium (ToxIC). Pediatric exposures reported to the Toxicology Investigators Consortium, 2010-2015. Pediatr Emer Care. 2019;0:1-5. View Publication

4. Friedman N, Shoshani-Levy M, Bren J, Wax P, Campleman SL, Finkelstein Y; the Toxicology Investigators Consortium (ToxIC). Fatalities in poisoned patients managed by medical toxicologists. Clin Toxicol (Phila). 2019;58(7):688-691. View Publication

5. Gauthey M, Capua M, Brent J, Finkelstein Y; Toxicology Investigators Consortium (ToxIC). Poisoning with malicious or criminal intent: Characteristics and outcome of patients presenting for emergency care. Clin Toxicol (Phila). 2019;57(7):628-631. View Publication

6. Moss MJ, Hendrickson RG; On behalf of the Toxicology Investigators Consortium (ToxIC). Serotonin Toxicity: Associated Agents and Clinical Characteristics. J Clin Psychopharmacol. 2019;39:628-633. View Publication

7. Murray BP, Carpenter JE, Dunkley CA, Moran TP, Alfaifi M, Alsukaiti WS, Kazzi Z; On behalf of the Toxicology Investigators Consortium (ToxIC). Seizures in Tramadol Overdoses Reported in the ToxIC Registry: Predisposing Factors and the Role of Naloxone. Clin Toxicol (Phila). 2019;57(8):692-696. View Publication

8. Spyres MB, Farrugia LA, Kang AM, Calello DP, Campleman SL, Pizon A, Wiegand T, Kao L, Riley BD, Li S, Wax PM, Brent J; On behalf of the Toxicology Investigators Consortium (ToxIC) Study Group. The Toxicology Investigators Consortium Case Registry-the 2018 Annual Report. J Med Toxicol. 2019;15(4):228-254. View Publication

2018

1. Beauchamp GA, Carey JL, Adams T, Wier A, Colón MF, Cook M, Cannon R, Katz KD, Greenberg MR; Toxicology Investigators Consortium (ToxIC). Sex differences in poisonings among older adults: An analysis of the Toxicology Investigators Consortium (ToxIC) Registry, 2010 to 2016. Clin Ther. 2018;40(8):1366-1374. View Publication

2. Farrugia LA, Rhyee SH, Campleman SL, Judge B, Kao L, Pizon A, Porter L, Riederer AM, Wiegand T, Calello D, Wax PM, Brent J; Toxicology Investigators Consortium (ToxIC) Study Group. The Toxicology Investigators Consortium Case Registry – The 2017 Annual Report. J Med Toxicol. 2018;14(4):182-211. View Publication

3. Gilley M, Brent J, Calello DP, Wax P, Finkelstein Y; Toxicology Investigators Consortium. Synthetic cannabinoid exposure in adolescents presenting for emergency care. Pediatr Emerg Care. 2018;0:1-4. View Publication

4. Kleinschmidt K, Ruha AM, Campleman S, Brent J, Wax P. Acute adverse events associated with the administration of Crotalidae polyvalent immune Fab antivenom within the North American Snakebite Registry. Clin Toxicol (Phila). 2018;24:1-6. View Publication

2017

1. Farrugia LA, Rhyee SH, Calello DP, Campleman SL, Riederer AM, Malashock HR, Pizon A, Wiegand T, Wax PM, Brent J.  The Toxicology Investigators  Consortium Case Registry – The 2016 Experience. Toxicology Investigators Consortium Study Group. J Med Toxicol. 2017;13(3):203-226. View Publication

2. Finkelstein Y1, Goel G, Hutson JR, Armstrong J, Baum CR, Wax P, Brent J; Toxicology Investigators Consortium (ToxIC). Drug misuse in adolescents presenting to the emergency department. Pediatr Emerg Care. 2017;33(7):451-456. View Publication

3. Heise CW, Malashock H, Brooks DE. A review of vilazodone exposures with focus on serotonin syndrome effects. Clin Toxicol (Phila). 2017;55(9):1004-1007. View Publication

4. Ho JH, Leikin JB, Dargan PI, Archer JRH, Wood DM, Brent J. Metal-on-Metal hip joint prostheses: A retrospective case series investigating the association of systemic toxicity with serum cobalt and chromium concentrations. J Med Toxicol. 2017;13(4):321-328.  View Publication

5. Monte AA, Calello DP, Gerona RR, Hamad E, Campleman SL, Brent J, Wax P, Carlson RG; ACMT Toxicology Investigators Consortium (ToxIC). Characteristics and treatment of patients with clinical illness due to synthetic cannabinoid inhalation reported by medical toxicologists: A ToxIC Database Study. J Med Toxicol. 2017;13(2):146-152. View Publication

6. Rasimas JJ, Smolcic EE, Sinclair CM. Themes and trends in intentional self-poisoning: Perspectives from critical care toxicology. Psychiatry Res. 2017;255:304-313. View Publication

7. Ruha AM, Kleinschmidt KC, Greene S, Spyres MB, Brent J, Wax P, Padilla-Jones A, Campleman S; ToxIC Snakebite Study Group. The epidemiology, clinical course, and management of snakebites in the North American Snakebite Registry. J Med Toxicol. 2017;13(4):309-320. View Publication

8. Spyres MB, Ruha AM, Kleinschmidt K, Vohra R, Smith E, Padilla-Jones A. Epidemiology and clinical outcomes of snakebite in the elderly: A ToxIC database study. Clin Toxicol (Phila). 2017;13:1-5. View Publication

2016

1. Beauchamp GA, Hendrickson, RG, Hatten BW; Toxicology Investigators Consortium. Endotracheal intubation for toxicologic exposures: A retrospective review of Toxicology Investigators Consortium (ToxIC) cases. J Emerg Med. 2016;51(4):382-388. View Publication

2. Farrugia LA, Rhyee SH, Campleman SL, Ruha AM, Weigand T, Wax PM, Brent J; Toxicology Investigators Consortium. The Toxicology Investigators Consortium Case Registry – The 2015 Experience. J Med Toxicol. 2016;12(3):224-47. View Publication

3. Judge BS, Ouellette LM, VandenBerg M, Riley BD, Wax PM; On behalf of the ACMT Toxicology Investigators Consortium (ToxIC). Utilization of observation units for the care of poisoned patients: Trends from the Toxicology Investigators Consortium Case Registry. J Med Toxicol. 2016;12:111-120. View Publication

4. Riederer, AM, Campleman Sl, Carlson RG, Boyer EW, Manini AF, Wax PM, Brent JA; Toxicology Investigators Consortium (ToxIC). Acute poisonings from synthetic cannabinoids—50 US Toxicology Investigators Consortium Registry Sites, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65(27);692–695. View Publication

5. Spyres MB, Ruha AM, Seifert S, Onisko N, Padilla-Jones A, Smith EA. Occupational snake bites: A prospective case series of patients reported to the ToxIC North American Snakebite Registry. J Med Toxicol. 2016;12(4):365-369. View Publication

6. Wang GS, Levitan R, Wiegand TJ, Lowry J, Schult RF, Yin S. Extracorporeal Membrane Oxygenation (ECMO) for severe toxicological exposures: Review of the Toxicology Investigators Consortium (ToxIC). J Med Toxicol. 2016;12(1):95-9. View Publication

2015

1. Finkelstein Y, Goel G, Hutson JR, Armstrong J, Baum CR, Wax P, Brent J. Drug misuse in adolescents presenting to the emergency department. Pediatr Emerg Care. 2015;33(7):451-456. View Publication

2. Froberg BA, Levine M, Beuhler MC, Judge BS, Moore PW, Engebretsen KM, Mckeown NJ, Rosenbaum CD, Young AC, Rusyniak DE. Acute Methylenedioxypyrovalerone Toxicity. J Med Toxicol. 2015;11(2):185-94. View Publication

3. Rhyee SH, Farrugia L, Campleman SL, Wax PM, Brent J. The Toxicology Investigators Consortium Case Registry—the 2014 Experience. J Med Toxicol. 2015;11(4):388-409. View Publication

4. Smith SW, Farmer BM. Toxicology in the service of patient and medication safety: A selected glance at past and present innovations. J Med Toxicol. 2015;11(2):245-252. View Publication

5. Watkins JW, Schwarz ES, Arroyo-Plasencia AM, Mullins ME. The use of Physostigmine by toxicologists in anticholinergic toxicity. J Med Toxicol. 2015;11(2):179-84. View Publication

6. Zelner I, Matlow J, Hutson JR, Wax P, Karen G, Brent J, Finkelstein Y. Acute poisoning during pregnancy: Observations from the Toxicology Investigators Consortium. J Med Toxicol. 2015;11(3):301-8. View Publication

2014

1. Rhyee S, Farrugia L, Wiegand T, Smith EA, Wax PM, Brent J. The Toxicology Investigators Consortium Case Registry—the 2013 Experience. J Med Toxicol. 2014;10(4):342-59. View Publication

2013

1. Finkelstein Y, Hutson JR, Freedman SB, Wax PM, Brent J. Drug-induced seizures in children and adolescents presenting for emergency care: Current and emerging trends.Clin Toxicol (Phila). 2013;51:761-6. View Publication

2. Wiegand TJ, Wax PM, Smith E, Hart K, Brent J. The Toxicology Investigators Consortium Case Registry—The 2012 Experience. J Med Toxicol. 2013;9(4):380-404. View Publication

2012

1. Finkelstein Y, Hutson JR, Wax PM, Brent J. Toxico-Surveillance of infant and toddler poisonings in the United States. J Med Toxicol. 2012;8:263-6. View Publication

2. Geib AJ, Liebelt E, Manini AF; Toxicology Investigators’ Consortium (ToxIC). Clinical experience with intravenous lipid emulsion for drug-induced cardiovascular collapse. J Med Toxicol. 2012 Mar;8(1):10-4. View Publication

3. Wiegand TJ, Wax PM, Schwartz T, Finkelstein Y, Gorodetsky R, Brent J. The Toxicology Investigators Consortium Case Registry—The 2011 Experience. J Med Toxicol. 2012;8:360-77. View Publication

 2011

1. Brent J, Wax PM, Schwartz T, Kleinschmidt KC, Engebretsen K, Beuhler M. The Toxicology Investigators Consortium Case Registry—The 2010 Experience. J Med Toxicol. 2011;7(4):266-76. View Publication

2. Wax PM, Kleinschmidt KC, Brent J. The Toxicology Investigators Consortium (ToxIC) Registry. J Med Toxicol. 2011;7(4):259-65. View Publication

Published Abstracts

The following list of abstracts based on ToxIC data have been published and presented at national and international meetings.

View all abstracts by year. Use CTRL-F (PC) or Command-F (Mac) to search publications by keyword, topic, or author.

2022

1. Aldy K, Krotulski A, Campleman S, Meyn A, Abston S, Logan B, Brent J, Wax P, Manini A; On Behalf of the Toxicology Investigators Consortium (ToxIC) Fentalog Study Group. Para-Fluorofentanyl Detected in Patients with Suspected Opioid Overdose. J Med Tox. 2022;18:107-108. View Abstract

2. Amaducci A, Aldy K, Campleman S, Meyn A, Abston S, Krotulski A, Logan B, Wax P, Brent J, Manini A; On Behalf of the Toxicology Investigators Consortium (ToxIC) Fentalog Study Group. Brorphine, Isotonitazene and Metonitazene Emerge as New Age Opioids. J Med Tox. 2022;18:87-88. View Abstract

3. Atti S, Ryan E, Rushton W, Beuhler M, Shaker K, Aldy K, Campleman S, Wax P, Brent J, Ruha M; On Behalf of the Toxicology Investigators Consortium (ToxIC) North American Snakebite Study Group. Snake Bites in Diabetic Patients: A Descriptive Analysis. J Med Tox. 2022;18:97. View Abstract

4. Burris O, Edric Wong, E, Dodson N, Rianprakaisang T; On Behalf of the Toxicology Investigators Consortium (ToxIC). Review of Recent Herbicide ExposuresJ Med Tox. 2022;18:104-105. View Abstract

5. Burris O, Wong E, Dodson N, Rianprakaisang T; On Behalf of the Toxicology Investigators Consortium (ToxIC). Review of Recent Rodenticide ExposuresJ Med Tox. 2022;18:105. View Abstract

6. Calello D, Jefri M, Nguyen T-A, Aldy K, Campleman S, Krotulski A, Logan B, Wax P, Brent J, Manini A; On Behalf of the Toxicology Investigators Consortium (ToxIC) Fentalog Study Group. Identification of a Novel Opioid, N-piperidinyl etonitazene in Patients with Suspected Opioid OverdoseJ Med Tox. 2022;18:109-110. View Abstract

7. Chettat S, Stephani J, Hendrickson R,; On Behalf of the ToxIC Investigators Consortium (ToxIC). Drug And Toxicant-associated Rhabdomyolysis: Clinical and Epidemiologic Trends. J Med Tox2022;18:81-82. View Abstract

8. Farah R, Kazzi Z, Brent J, Burkhart K, Wax P, Aldy K; On Behalf of the Toxicology Investigators Consortium (ToxIC) FACT Study Group. Ivermectin Associated Adverse Events in the Treatment and Prophylaxis of COVID-19 Reported to the FDA ACMT COVID-19 ToxIC (FACT) Pharmacovigilance Project Study GroupJ Med Tox. 2022;18:79. View Abstract

9. Hughes A, Hendrickson R,  Aldy K, Campleman S, Meyn A, Krotulski A, Logan B, Wax P, Brent J, Manini A; On Behalf of the Toxicology Investigators Consortium (ToxIC) Fentalog Study Group. Co-presence of Mitragynine and Fentanyl in Emergency Department Patients with Suspected Opioid Overdose. J Med Tox2022;18:87. View Abstract

10. Levine M, Aldy K, Meyn A, Campleman, Krotulski A, Logan B, Wax P, Brent J, Manini A; On behalf of the Toxicology Investigators Consortium (ToxIC) Fentalog Study Group. Prevalence Of Adulterants in Acute Opioid Toxic Patients. J Med Tox. 2022;18:76-77. View Abstract

11. Olives T, Hendrickson A, Meyn A, Campleman S, Abston S, Wax P, Brent J, Aldy K; On Behalf of the Toxicology Investigators Consortium (ToxIC) FACT Study Group. Burden of Adverse Events Related to the Treatment of COVID19 by Race/Ethnicity. J Med Tox. 2022;18:82. View Abstract

12. Schwarz E, Aldy K, Meyn A, Campleman S, Li S, Krotulski A, Logan B, Wax P, Brent J, Manini A; On Behalf of the Toxicology Investigators Consortium (ToxIC) Fentalog Study Group. Tramadulterant: Tramadol Detected in Patient’s Serum Following An Acute Opioid OverdoseJ Med Tox. 2022;18:109. View Abstract

13. Shastry S, Aldy K, Campleman S, Meyn A, Abston S, Krotulski A, Logan B, Brent J, Wax P, Manini A; On Behalf of the Toxicology Investigators Consortium (ToxIC). Psychostimulant Drug Co-ingestion in Emergency Department Patients with Opioid Overdose: a Multi-Center ToxIC CollaborationJ Med Tox. 2022;18:108-109. View Abstract

14. Shastry S et al. Psychostimulant drug co-ingestion in emergency department patients with opioid overdose: a multi-center ToxIC Collaboration. Presented at the European Association of Poisons Centres and Clinical Toxicologists 2022, Tallinn, Estonia. Clin Toxicol 2022; 60 (S1):35-36. View Abstract

15. Simon M, Heard K; On Behalf of the Toxicology Investigators Consortium (ToxIC). Antimuscarinic or Asleep: A Comparison of Antimuscarinic Effects Between Hydroxyzine and Diphenhydramine Poisoned PatientsJ Med Tox. 2022;18:112-113. View Abstract

2021

1. Aldy K, Wax P, Brent J, Marshall S, Campleman S, Abston S, Meyn A, Diak IL, Konkel K, Mundkur M, Dang O, Burkhart K; On behalf of the ToxIC FACT Study Group. Rapid Development of the FDA ACMT COVID-19 ToxIC (FACT) Pharmacovigilance Pilot Project to Monitor Adverse Events Reported in Association with COVID-19 Therapeutics. Clin Toxicol (Phila). 2021; 59(11):1054. View Abstract

2. Amaducci A, Aldy K, Meyn A, Campleman S, Li S, Krotulski A, Logan B, Hughes A, Pizon A, Shulman J, Schwarz E, Wax P, Brent J, Manini AF; On behalf of the ToxIC Fentalog Study Group. Clonazolam and Fentanyl: What’s in Your Local Drug Supply? Clin Toxicol (Phila). 2021; 59(11):1061-1062. View Abstract

3. Amaducci A, Aldy K, Campleman S, Li S, Meyn A, Abston S, Spyres MB, Wax P, Brent J; On behalf of the Toxicology Investigators Consortium. Toxicological Exposures in COVID-19 Patients. Clin Toxicol (Phila). 2021; 59(11):1159-1160. View Abstract

4. Basse J, Greene S, Ruha AM, Baumgartner K, Mullins M, Wax P, Brent J, Campleman S, Schwarz E; On Behalf of the ToxIC Investigators Consortium (ToxIC). Clinical Presentations, Treatments, and Outcomes of Exotic Snake Envenomations in the United States. J Med Tox. 2021;17:100-101. View Abstract

5. Camarena-Michel A, Martinez AE, Hoyte C; On behalf of the Toxicology Investigators Consortium. Access to opioid treatment facilities in opioid overdose patients by race and ethnicity on behalf of the ACMT Toxicology Investigators Consortium (ToxIC). Clin Toxicol (Phila). 2021; 59(11):1081-1082. View Abstract

6. Carey J, Babu K, Merchant R; On behalf of the Toxicology Investigators Consortium. Does hepatotoxicity occur more frequently among American Indians/ Alaskan natives after acetaminophen overdose? Clin Toxicol (Phila). 2021; 59(11):1149-1150. View Abstract

7. Carey JL, Boyle KL, Aldy K, Campleman S, Abston S, Meyn A, Wax P, Brent J; On behalf of the ToxIC FACT Study Group. Adverse Drug Events Associated with Monoclonal Antibodies Used in the Treatment of COVID-19. Clin Toxicol (Phila). 2021; 59(11):1053-1054. View Abstract

8. Cohen N, Mathew M, Davis A, Brent J, Wax P, Schuh S, Freedman SB, Froberg BA, Schwarz E, Canning J, Tortora L, Hoyte C, Koons A, Burns MM, McFalls J, Weigand TJ, Hendrickson RG, Judge B, Quang LS, Hodgman M, Chenoweth JA, Algren DA, Carey J, Caravati EM, Akpunonu P, Geib AJ, Seifert SA, Kazzi Z, Othong R, Greene SC, Holstege C, Tweet MS, Vearrier D, Pizon A, Aldy K, Campleman SL, Li S, Finkelstein Y; On behalf of the Toxicology Investigators Consortium. Predictors of severe outcome following opioid overdose in children: a case-control study of a prospective toxicology surveillance registry. Clin Toxicol (Phila). 2021; 59(11):1172. View Abstract

9. Devgun J, Aldy K, Campleman S, Abston S, Meyn A, Brent J, Wax P; On behalf of the ToxIC FACT Study Group. Remdesivir Associated Bradycardia Identified through the FDA ACMT COVID-19 ToxIC (FACT) Pharmacovigilance Project. Clin Toxicol (Phila). 2021; 59(11):1052. View Abstract

10. Dodson N, Wong E, Rianprakaisang T; On behalf of the Toxicology Investigators Consortium. Comparing clinical features of benzodiazepine overdoses: a review of the Toxicology Investigators Consortium registry. Clin Toxicol (Phila). 2021; 59(11):1115-1116. View Abstract

11. Filip A, Berg S, Mullins M, Schwarz E; On Behalf of the ToxIC Investigators Consortium (ToxIC). Fomepizole As An Adjunctive Therapy For Acetaminophen Poisoning: Cases Reported To The Toxicology Investigators Consortium (ToxIC) Database 2015-2020. J Med Tox. 2021;17:96. View Abstract

12. Hack K, Mazer-Amirshahi M, Campleman S, Karshenas D, Pizon A; On Behalf of the ToxIC Investigators Consortium (ToxIC). Observations Impacting Pregnancy in the ToxIC Registry. J Med Tox. 2021;17:142–143. View Abstract

13. Hughes A, Aldy K, Meyn A, Campleman S, Li S, Krotulski A, Logan B, Amaducci A, Pizon A, Wax P, Brent J, Manini AF; On behalf of the ToxIC Fentalog Study Group. Designer benzodiazepines etizolam and flubromazolam detected in patients with suspected opioid overdose. Clin Toxicol (Phila). 2021; 59(11):1047-1048. View Abstract

14. Kaiser S, Rague J, Smith K, Weiss S; On behalf of the Toxicology Investigators Consortium. A secondary analysis of adverse events and naloxone administration in intentional kratom exposures from 2013 – 2020 using the Toxicology Investigators Consortium (ToxIC) registry. Clin Toxicol (Phila). 2021; 59(11):1130-1131. View Abstract

15. Lavonas EJ, Dalton AM, Olson R, Rapp-Olsson M, Reynolds K, Ruha AM, Campleman S, Aldy K, Dart RC, On behalf of the North American Snakebite Study Group. Most Rattlesnake Envenomation Patients Receive Multiple Doses of AntivenomAnnals of Emergency Medicine; 2021; 78(4): S30-S31. View Abstract

16. Lavonas EJ, Rapp-Olsson M, Dalton AM, Reynolds AM, Dart RC; On Behalf of the ToxIC Investigators Consortium (ToxIC). Most Rattlesnake Envenomation Patients Receive Multiple Doses of Antivenom. Acad Emerg Med. 2021; 28 (Suppl. 1): S86. View Abstract

17. Levine M, Aldy K, Meyn A, Campleman S, Krotulski A, Logan B, Hughes A, Schwarz E, Pizon A, Wax P, Brent J, Manini AF; On behalf of the ToxIC Fentalog Study Group. Adulteration of Illicit Drugs in ED Patients with Acute Opioid Overdose: A Multicenter CohortClin Toxicol (Phila). 2021; 59(11):1067. View Abstract

18. Lewis B, Judge B; On Behalf of the ToxIC Investigators Consortium (ToxIC). Gastrointestinal Decontamination: Trends from the ToxIC Case Registry, A Five-Year Review. J Med Tox. 2021;17:144. View Abstract

19. Love J, Aldy K; On Behalf of the ToxIC Investigators Consortium (ToxIC).Fatality Trends Using the Toxicology Investigator’s Consortium (ToxIC) Registry: A 6-year Review of Demographics and Clinical Characteristics. J Med Tox. 2021;17:143. View Abstract

20. Love J, Aldy K; On Behalf of the ToxIC Investigators Consortium (ToxIC). Treatment Modality Trends in Fatalities Reported to the Toxicology Investigator’s Consortium (ToxIC) Registry: A Six Year Review. J Med Tox. 2021;17:143-144. View Abstract

21. Manini AF, Krotulski A, Allen LR, Brent J, Samame V, Vidal K, Wax P, Logan B; On Behalf of the ToxIC Investigators Consortium (ToxIC).  Fentanyl and fentanyl analogues in emergency department patients with suspected heroin overdose in the pre-COVID- 19 era. Acad Emerg Med. 2021; 28 (Suppl. 1): S85. View Abstract

22. Nguyen H, Amaducci A, Hoyte C; On behalf of the Toxicology Investigators Consortium. Toxicologic exposures in transgender patients during the SARS- CoV2 pandemic. Clin Toxicol (Phila). 2021; 59(11):1071. View Abstract

23. Obilom C, McFalls J, Epperson L, Shaker K, Brent J, Wax P, Aldy K; On Behalf of the ToxIC Investigators Consortium (ToxIC). A Look Back: E-Cigarette, or Vaping, Product Use Associated Lung Injury (EVALI) Before and After the COVID-19 Pandemic. J Med Tox. 2021;17:99. View Abstract

24. Pitotti C, Kaplan S, Ruha AM, Wolk B, Hoyte C; On behalf of the North American Snakebite Study Group. Characterization of F(ab’)2 and Fab crotalidae antivenom single and combination therapy 2018-2020: retrospective analysis of the North American Snakebite Registry. Clin Toxicol (Phila). 2021; 59(11):1038-1039. View Abstract

25. Schwarz E, Aldy K, Meyn A, Campleman S, Li S, Krotulski A, Logan B, Wax P, Brent J, Manini AF; On behalf of the ToxIC Fentalog Study Group. Clinical effects and treatment of patients following overdoses of brorphine and butyrylfentanyl. Clin Toxicol (Phila). 2021; 59(11):1060. View Abstract

26. Schwarz ES, Spyres MB, Aldy K, Campleman S, Li S, Meyn A, Abston S, Wax P, Brent J; On behalf of the Toxicology Investigators Consortium. Teletoxicology in the time of COVID. Clin Toxicol (Phila). 2021; 59(11):1138-1139. View Abstract

27. Simon M, Heard K; On behalf of the Toxicology Investigators Consortium. All antihistamines are not the same: a comparison of antimuscarinic effects between hydroxyzine and diphenhydramine poisoned patients. Clin Toxicol (Phila). 2021; 59(11):1103. View Abstract

28. Spyres M, Makar G, Meadors K, Ruha AM;On behalf of the ToxIC North American Snakebite Study Group. Compartment syndrome and rattlesnake envenomation: a review of the NASBR subregistry 2013-2020. Clin Toxicol (Phila). 2021; 59(11):1123. View Abstract

29. Wax PM, Aldy K, Brent J, On behalf of the Toxicology Investigators Consortium FACT Study Group; Rapid Development of the FDA ACMT COVID-19 ToxIC (FACT) Pharmacovigilance Pilot Project to Monitor Adverse Events Reported in Association with COVID-19 TherapeuticsToxicol Lett. 2021;350:S20. View Abstract

30. Wong E, Dodson N, Rianprakaisang; On behalf of the Toxicology Investigators Consortium. Comparing clinical features of benzodiazepine and z-drug overdoses: a review of the Toxicology Investigators Consortium registry. Clin Toxicol (Phila). 2021; 59(11):1095. View Abstract

2020

1. Aldy KN, Cao D, Billington M, McFalls J, Obilom C, Wax P, in collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Effect of Diagnostic Findings on Treatment and Patient Outcome in E-cigarette, or Vaping, Product Use Associated Lung Injury (EVALI). J Med Tox. 2020;16:75-86. View Abstract

2. Aldy KN, Cao D, Billington M, McFalls J, Obilom C, Wax P, in collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Effects of Patient and Use Characteristics on Symptoms and Outcome in E-Cigarette, or Vaping, Product Use Associated Lung Injury (EVALI). J Med Tox. 2020;16:75-86. View Abstract

3. Aldy KN, Cao D, Wax P, Brent J, Calello D, Campleman S, in collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Establishing a Rapid Surveillance Response for E-cigarette, or Vaping, Product Use Associated Lung Injury (EVALI) Using the ToxIC Registry. J Med Tox. 2020;16:75-86. View Abstract

4. Baumgartner KT, Schwarz ES, in collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Treatment of Beta Blocker and Calcium Channel Antagonist Poisoning by Medical Toxicologists. J Med Tox. 2020;16:75-86. View Abstract

5. Billington MER, Aldy K, Wax P, Cao DJ, in collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Steroid Statistics: a Regional Review of the Use of Systemic Steroids in the Treatment of Electronic Vaping-Associated Lung Injuries (EVALI). J Med Tox. 2020;16:75-86. View Abstract

6. Brent J, in collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Lack of Predictive Value of Provoked Urine Test Results in the Determination of Toxic Exposures. J Med Tox. 2020;16:75-86. View Abstract

7. Calello DP, Aldy K, Campleman S, Wax P, Brent J, in collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Management Trends in the Toxicology Investigators Consortium Registry: a 10-Year Review. J Med Tox. 2020;16:75-86. View Abstract

8. Campleman S, Li S, Brent J, Calello D, Wax P, in collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Ten-Year Trends in Reporting of Methamphetamine and Heroin Exposure as Treated by Medical Toxicologists: 2010–2019. J Med Tox. 2020;16:75-86. View Abstract

9. Chen RJ, Ershad M, Campleman S, Vearrier D, in collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Epidemiology and Treatment of Z-Drug Toxicity as Reported by Medical Toxicologists: a ToxIC Database Study. J Med Tox. 2020;16:75-86. View Abstract

10. Daigh AW, Varney SM, Huang M, Gelfond JA, Brent J, in collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Dantrolene Sodium in Neuroleptic Malignant Syndrome: Is There a Benefit? J Med Tox. 2020;16:75-86. View Abstract

11. Fishburn SJ, Schwarz ES, in collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Characterizing Occupational and Environmental Exposures inthe ACMT Toxicology Investigators Consortium Database. J Med Tox. 2020;16:75-86. View Abstract

12. Friedman N, in collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Fatalities in Poisoned Patients Managed by Medical Toxicologists. J Med Tox. 2020;16:75-86. View Abstract

13. Hurwitz MB, McWhirter CR, Laubach LT, Beauchamp GA, Sabino JN, Careyva BA, Cook MD, Greenberg MR, Cannon RD, Surmaitis RM, in collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Agents of Exposure in Transgender Patient Cases Managed by a Toxicologist: an Analysis of the Toxicology Investigator’s Consortium (ToxIC) Registry. J Med Tox. 2020;16:75-86. View Abstract

14. Manini AF, Brent J, Campleman S, Judge BS, Kao L, Loo G, Pizon AF, Ruha A, Wiegand T, Wax P, Toxicology Investigators Consortium (ToxIC) Study Group. Validation of a Prediction Rule for Adverse Cardiovascular Events from Drug Overdose. Ann Emerg Med. 2020;76(4S):S6. View Abstract

15. Pizon AF, Wax P, Campleman S, Karshenas D, Brent J, in collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Quality Measures for Medical Toxicology Patients: an 18-Month Update. J Med Tox. 2020;16:75-86. View Abstract

16. Wax P, in collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Quality Performance Measures in Medical Toxicology. J Med Tox. 2020;16:75-86. View Abstract

2019

1. Barbuto A, Chary M, Burns M, In collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Octreotide Use By Medical Toxicologiests: An Analysis from the ToxIC RegistryJ Med Tox. 2019, 15:85. View Abstract

2. Camarena-Michel A, Hatten B, In collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Racial and Ethnic Patterns of Intentional Overdose. J Med Tox. 2019, 15:63. View Abstract

3. Campleman S, Wax P, Pizon A, Karshenas D, Brent J, In collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Screening for Risk of Opioid Misuse and Overuse by Medical Toxicologists. J Med Toxic 2019, 15:89. View Abstract

4. Carreiro S, Miller S, Wang B, Wax P, Campleman S, Manini A, In collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Clinical Predictors of Adverse Cardiocascular Events for Acute Pediatric Drug Exposures. J Med Toxic 2019, 15:87. View Abstract

5. Hughes A, Blumenberg A, Murphy L, Rianprakaisang T, Hendrickson R, In collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Predictors of Poisoning Severity in Diphenhydramine Overdose. J Med Toxic 2019, 15:74. View Abstract

6. Mazer-Amirshahi M, Riederer A, Campleman S, Calello D, Burkhart K, Brent J, Wax P, In collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Increasing Misuse and Abuse of Gabapentin and Pregabalin J Med Toxic 2019, 15:75. View Abstract

7. Murray B, Carpenter J, Dunkley C, Moran T, Alsukaiti W, Alfaifi M, Kazzi Z, In collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Single Agent Bupropion Overdose: Effects as Reported in the ToxIC Registry.  J Med Toxic 2019, 15:60. View Abstract

8. Pizon A, Wax P, Campleman S, Karshenas D, Brent J, In collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Implementing a Quality Measure Performance Program for Medical Toxicology Patients.  J Med Toxic 2019, 15:95. View Abstract

9. Rianprakaisang T, Prather C, Blumenberg A, Murphy L, Hughes A, Hendrickson R, In collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Does Co-Ingestion with Benzodiazepines Reduce the Rate of Seizures in Overdose? A Review of the Toxicology Investigators Consortium Database.  J Med Toxic 2019, 15:61. View Abstract

10. Rianprakaisang T, Prather C, Murphy L, Blumenberg A, Hughes A, Hendrickson R, In collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Rates of Serotonin Toxicity and Factors Associated with Seisures in SNRI Overdose: A Review of the Toxicology Investigators Consortium DatabaseJ Med Toxic 2019, 15:86. View Abstract

11. Spyres M, Mazer-Amirshahi M, Riederer A, Campleman S, Wax, P, Brent J, In collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Utilizing the ToxIC Network to Assess the Impact of Opioid and Benzodiazepine Misuse/Abuse on Older Adults.  J Med Toxic 2019, 15:87. View Abstract

12. Wax P, Pizon A, Campleman S, Karshenas D, Brent J, In collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). ECG Assessment in Acute Overdose. J Med Toxic 2019, 15:96. View Abstract

13. Wax P, Pizon A, Campleman S, Karshenas D, Brent J, In collaboration with the ACMT Toxicology Investigators Consortium (ToxIC). Pregnancy Testing in Toxicological EvaluationsJ Med Toxic 2019, 15:96. View Abstract

2018

1. Beauchamp G, Carey J, Adams T, Colón M, Cook M, Cannon R, Katz K, Wier A, Rayl Greenberg M, On behalf of the Toxicology Investigators Consortium (ToxIC). Sex Differences in Poisonings Among Older Adults: an Analysis of the Toxicology Investigators Consortium (ToxIC) Registry: 2010–2016. J Med Toxic 2018,14:35. View Abstract

2. Beauchamp G, Carey J, Cook M, Cannon R, Katz K, Ely B, Pollack E, Mazzaccaro R, Rayl Greenberg M, On behalf of the Toxicology Investigators Consortium (ToxIC). Sex Differences in Pediatric Poisonings: an Analysis of the Toxicology Investigators Consortium (ToxIC) Registry: 2010–2016.  J Med Toxic 2018,14:60. View Abstract

3. Beauchamp G, Carey J, Tully B, Cook M, Cannon R, Katz K, Rayl Greenberg M, On behalf of the Toxicology Investigators Consortium (ToxIC). Sex Differences in Adult Abuse and Misuse Cases: an Analysis of the Toxicology Investigators Consortium (ToxIC) Registry: 2010–2016. J Med Toxic 2018,14:45. View Abstract

4. Beauchamp G, Greenberg MR, Meyers M, Cook M, Cannon R, Katz K, Amaducci A, Finkelstein Y, On Behalf of the Toxicology Investigators Consortium (ToxIC). Adverse Drug Events and Reactions Managed by Medical Toxicologists: an Analysis of the Toxicology Investigators Consortium (ToxIC) Registry, 2010–2016. J Med Toxic 2018,14:44-45. View Abstract

5. Bruccoleri R, Davey M, Spyres M, Manini A, Dela Cruz M, Burns M, On Behalf of the ToxIC Consortium (ToxIC). Sodium Bicarbonate Therapy: Treatment Recommendations and Clinical Outcomes as Reported Through the ToxIC Registry. J Med Toxic 2018,14:52. View Abstract

6. Camarena-Michel A, Hatten B. Racial and ethnic characteristics in cases of intentional pharmaceutical exposure with concern for toxicity. Clinical Toxicology 2018,56:520-521. View Abstract

7. Camarena-Michel A, Hoyte C, On Behalf of the ToxIC Investigators Consortium (ToxIC). Characteristics of Corticosteroid Use Across Various Toxic Exposures. J Med Toxic 2018,14:34. View Abstract

8. Camarena-Michel A, Hoyte C, On Behalf of the ToxIC Investigators Consortium (ToxIC). The Frequency of Seizures After Exposure in Cases with QRS Interval Prolongation. J Med Toxic 2018,14:33. View Abstract

9. Campleman S, Wax P, Brent J, Manini A, On Behalf of the ToxIC Investigators Consortium (ToxIC). Drug-Specific Risk of Severe QT Prolongation Following Acute Drug Overdose.  J Med Toxic 2018,14:32. View Abstract

10. Gilley M, Brent J, Calello D, Wax P, Finkelstein Y, On Behalf of the ToxIC Investigators Consortium (ToxIC). Synthetic Cannabinoid Exposure in Adolescents Presenting for Emergency Care.  J Med Toxic 2018,14:18. View Abstract

11. King J, Rege S, Murphy C, Hatten B, Haynes A, On Behalf of the ToxIC Investigators Consortium (ToxIC). ToxIC Extracorporeal Therapies SubRegistry: Update 2017 J Med Toxic 2018,14:54. View Abstract

12. Moss M, Hendrickson R, On Behalf of the ToxIC Investigators Consortium (ToxIC). Serotonin Toxicity Case Characteristics and Associated Xenobiotics: a Review of the Toxicology Investigators Consortium (ToxIC) Database.  J Med Toxic 2018,14:40. View Abstract

13. Noori M, Hendrickson R, Hatten B. Kratom: natural painkiller or herbal enemy?  Clinical Toxicology 2018,56:574. View Abstract

14. Rianprakaisang T, Hendrickson R, On Behalf of the ToxIC Investigators Consortium (ToxIC). Factors Associated with Seizures in Bupropion Overdose: a 3-Year Review of the ToxIC Registry. J Med Toxic 2018,14:23. View Abstract

15. Ruha AM, Gerkin R, Wolk B, Caravati E, Brent J, Campleman S, Wax P, On Behalf of the ToxIC Investigators Consortium (ToxIC) North American Snake Bite Registry (NASBR). Association Between Initial Platelet Count and Antivenom Dose Following Rattlesnake Envenomation. J Med Toxic 2018,14:46. View Abstract

16. Shafer S, Campleman S, Haynes A, Callelo D, Wax P, Brent J, On Behalf of the ToxIC Investigators (ToxIC). Characteristics of Toxic Exposures in HIV-Positive Patients Reported to the Toxicology Investigators Consortium. J Med Toxic 2018,14:36. View Abstract

17. Spyres M, Choi Y, On Behalf of the ToxIC Investigators Consortium (ToxIC). Fentanyl Exposures: The ToxIC Experience 2010–2017J Med Toxic 2018,14:5. View Abstract

2017

1. Anderson SA, Dayan P, Calello D, Monte A, Oprescu A, Hurd Y , Manini A, On Behalf of the Toxicology Investigators Consortium (ToxIC). Increased Severity of Neuropsychiatric Outcomes with Acute Synthetic Cannabinoid Toxicity as Compared to Marijuana in Adolescents Presenting to Emergency Departments. J Med Toxic 2017,13:41-42. View Abstract

2. Campleman S, Wax P, Calello D, Brent J. Seven-year trends in the reporting of multiple agent exposures involving opioids and sedative-hypnotics/muscle relaxants to the ToxIC Registry, 2010-2016Clin Toxicol. 2017, 55(7):763. View Abstract

3. Campleman S, Riederer A, Wax P, Brent J, On Behalf of the Toxicology Investigators Consortium (ToxIC). Trends in the Occurrence of Opiate Exposure as Reported to the ToxIC Registry, 2010–2015. J Med Toxic 2017, 13: 38-39. View Abstract

4. Hatten B, On Behalf of the Toxicology Investigators Consortium (ToxIC). Hydrogen Peroxide Exposures Reported to the Toxicology Investigators Consortium (ToxIC). J Med Toxic 2017, 13: 17-18. View Abstract

5. Khalid MM, McCloskey, Vearrier D. Mushroom exposures in the United States reported to the Toxicology Investigator’s Consortium (ToxIC) registry. Clin Toxicol, 2017 55(7):779. View Abstract

6. Kleinschmidt K, Ruha A, Wax P, Brent J, Campleman S, On Behalf of the Toxicology Investigators Consortium NASBR. Acute Adverse Events Associated With The Administration of FabAV Within The North American Snakebite Registry. J Med Toxic 2017,3:4. View Abstract

7. Lee V, Vera A, Calello D, Ruck B, Nelson L, Campleman S, Wax P, Brent J. Loperamide misuse to avoid opioid withdrawal: high doses, high risk. Clin Toxicol 2017,55(7):781. View Abstract

8. Levine M, Ruha M, Vohra R, Wolk B, Spyres M, Brent J, Wax P, Campleman S, On Behalf of the Toxicology Investigators Consortium (ToxIC) NASBR. Comparison Of Pediatric Vs. Adult Rattlesnake Envenomations: The ToxIC Experience. J Med Toxic 2017, 13: 13. View Abstract

9. McCloskey K, Surmaitis R, Goldberger D, McKeever R. Characterizing benzodiazepine toxicities using the Toxicology Investigator’s Consortium (ToxIC) Registry. Clin Toxicol 2017 55(3):495. View Abstract

10. Rianprakaisang T, Farrugia L, Rhyee S, On Behalf of the Toxicology Investigators Consortium (ToxIC). Citalopram Ingestions: a Two Year Retrospective Study of the Toxicology Investigators Consortium. J Med Toxic 2017, 13: 7. View Abstract

11. Ruha A, Kleinschmidt K, Greene S, Spyres M, Wax P, Brent J, Padilla-Jones A, Campleman S, On Behalf of the Toxicology Investigators Consortium NASBR. The Epidemiologic and Clinical Characteristics of Snakebites in the North American Snakebite Registry. J Med Toxic 2017, 13: 4-5. View Abstract

12. Spyres M, Ruha A-M, Finkelstein Y, Levine M, Campleman. Pediatric marijuana ingestions: the ToxIC experience 2010-2016. Clin Toxicol. 2017, 55(7):798. View Abstract

13. Surmaitis R, McCloskey K, Goldberger D, Vearrier D. Characterizing the administration of fomepizole by medical toxicologists. Clin Toxicol. 2017, 55(3):393. View Abstract

14. Vo T, Hendrickson R, Hatten B. Plant and fungi exposures reported to the Toxicology Investigator’s Consortium (ToxIC). Clin Toxicol. 2017, 55(7):755. View Abstract

2016

1. Beauchamp GA, Hendrickson RG, Hatten BW. Endotracheal Intubation for Toxicologic Exposures: a Retrospective Review of Toxicology Investigators Consortium (ToxIC) Cases. J Med Toxicol. 2016 March, 12(1):41. View Abstract

2. Boroughf W, Bedi DS, Hayoun MA, Walsh SJ. Elder Toxicology: Characterizing Intentional Pharmaceutical Exposures in the Aged Population Using the ToxIC Registry. J Med Toxicol. 2016 March, 12(1):40. View Abstract

3. Boroughf W, Bedi DS, Hayoun MA, Walsh SJ. Elder Toxicology: Characterizing Unintentional Pharmaceutical Exposures in the Aged Population Using the ToxIC Registry. J Med Toxicol. 2016 March, 12(1):40-41. View Abstract

4. Bruccoleri RE, Davey M, Spyres MB, Burns MM. Current Treatment Recommendations and Clinical Outcomes of Sodium Bicarbonate Therapy on Sodium Channel Blocking Agents through the ToxIC Registry.  J Med Toxicol 2016 March, 12(1):39. View Abstract

5. Campleman S, Wax P, Brent J. Improving Sentinel Reporting in a Medical Toxicology Surveillance System by Strengthening Data Entry Requirements.  J Med Toxicol. 2016 March, 12(1):37. View Abstract

6. Campleman S, Wax P, Brent J. Opiate and Sedative-Hypnotics/Muscle Relaxants: Trends in Two Important Drug Classes as Reported to the ToxIC Registry, 2010–2014.  J Med Toxicol. 2016 March, 12(1):38. View Abstract

7. Campleman S, Wax P, Brent J. The Toxicology Investigator’s Consortium Registry: Descriptive Analysis of the First 5 Years 2010–2014.  J Med Toxicol. 2016 March, 12(1):37-38. View Abstract

8. Darracq MA, Vohra R, Ruha AM. Cutting to the Chase: Observations on Debridement in Crotalid Envenomation. ACMT ToxIC North American Snakebite Registry.  J Med Toxicol. 2016 March, 12(1):35. View Abstract

9. Fernandez D, NelsonLS, Repplinger DJ, Smith SW. Metformin Intentional Overdose and its Association with Metabolic Acidosis and Elevated Lactate—As Reported by Toxicologists. J Med Toxicol. 2016 March, 12(1):31-32. View Abstract

10. Ho J, Wax P, Leikin JB, Archer JRH, Wood DM, Dargan PI, Brent J. Metal-on-metal hip joint prostheses: a retrospective case series investigating association of systemic toxicity with serum cobalt and chromium concentrations. Clin Toxicol. 54(4):430. View Abstract

11. Levine M, Brent J, Wax P, et al. Prospective Cohort Study of Intravenous Lipid Emulsion for Resuscitating Critically Ill Poisoned Patients.  J Med Toxicol. 2016 March, 12(1):4. View Abstract

12. Moore EC, Vohra V, Wolk B, Ruha AM. Snakebite Neurotoxicity: a Retrospective Review of Patients Reported to the ToxIC North American Snakebite Registry. J Med Toxicol. 2016 March, 12(1):19. View Abstract

13. Othong R, Kazzi ZN. Descriptive study of medical toxicology consultations at a teaching university hospital in Bangkok. Clin Toxicol. 54(4):456. View Abstract

14. Rickner SS, Cao D, Kleinschmidt KC, et al. Assessment of Patterns of Substance Abuse among Adolescents and the Associated Severity of Outcome: a 5-Year Retrospective Cohort Study.  J Med Toxicol. 2016 March, 12(1):16. View Abstract

2015

1. Abar B, Derienzo V, Conner K, Botelho S, Wiegand TJ. Intentional Pharmaceutical Overdoses Related to Therapeutic Misadventures: A Description of ToxIC Entries.  J Med Toxicol. 2015 March,11;7. View Abstract

2. Arroyo-Plasencia AM, Schwarz E. Street Drug Exposures in Hospitalized Patients as Reported to the Toxicology Investigators Consortium Case Registry.  Clin Toxicol. 2015 53(7):697. View Abstract

3. Boyle KL, Farrugia LA, Carey JL. Characterization of Acute Opioid Overdose in the ToxIC Registry.  J Med Toxicol. 2015 March, 11;11. View Abstract

4. Boyle KL, Arrugia LA, Carey JL. Characterization of acute opioid overdose in the ToxIC Registry. Clin Toxicol. 2015 53:378. View Abstract

5. Bruccoleri RE, Burns MM. Characteristics and Treatments of Patients with ECG Findings Significant for QRS Widening. J Med Toxicol. 2015 March,11;11. View Abstract

6. Calello DP, Troncoso AB, Geib AJ. Bupropion: An Atypical Cause of Serotonin Syndrome Report from the ToxIC Registry. J Med Toxicol. 2015 March,11;12. View Abstract

7. Calello DP, Troncoso AB. Features of Synthetic Cannabinoid Exposures: Report from the ToxIC Registry. J Med Toxicol. 2015 March,11;12-13. View Abstract

8. Calello DP, Shih RD, Troncoso AB. Respiratory depression and ventilatory support in synthetic cannabinoid exposures: Report from the ToxIC Registry. Clin Toxicol. 2015 53:366. View Abstract

9. Cao D, Wax P. Characterization of Single Substance Baclofen Exposure in the Toxicology Investigators Consortium Registry. Clin Toxicol. 2015 53(7):685. View Abstract

10. Conner KR, Abar B, Derienzo V, Ashrafioun L, et al. Characteristics of Intentional Self-Poisonings in Adolescents versus Adults in ToxIC Case Registry Entries.  Clin Toxicol. 2015 53(7):715. View Abstract

11. Farrugia LA, Boyle KL, Carey JL. Suicidal Adolescents: Examining Self-Poisonings Within the Pediatric Population. J Med Toxicol. 2015 March, 11;16-17. View Abstract

12. Farrugia LA , Boyle KL , Carey JL. Suicidal adolescents: Examining self-poisonings within the pediatric population. Clin Toxicol. 2015 53:293-294. View Abstract

13. Hatten BW, Beauchamp GA. Toxic exposures in young children resulting in tracheal intubation.  Clin Toxicol. 2015 53:299. View Abstract

14. Hatten BW, Brent JA, Wax PM. Chemical Threat Agents Reported in the ToxIC Registry (2010-2013). J Med Toxicol. 2015 March, 11;21. View Abstract

15. Levine M, Finkelstein Y, Rhyee SH, Vearrier DJ, Leikin JB, Beuhler MC. Antidotal Therapy by Intravenous Lipid Emulsion: Observations from the Toxicology Investigators Consortium (ToxIC).  J Med Toxicol. 2015 March, 11;25. View Abstract

16. Onisko, NS, Kleinschmidt KC, Greene S, Bebarta V, Ruha AM, Padilla-Jones A. Characteristics of Acute Cottonmouth Envenomation from the ToxIC North American Snakebite Registry (NASBR). J Med Toxicol. 2015 March, 11;32-33. View Abstract

17. Ruha AM, Kang AM, Onisko NS, Greene S, Vohra R, Seifert SA, Smith E, Padilla-Jones A. Antibiotic Use in the Management of Snake Envenomation. J Med Toxicol. 2015 March, 11;36-37. View Abstract

18. Ruha AM, Spyres, MB, Kleinschmidt KC, Greene S, Vohra R, Smith E, Padilla-Jones A. Snakebite in the Elderly: A Retrospective Cohort of Patients Reported to the ToxIC North American Snakebite Registry. J Med Toxicol. 2015 March, 11;37. View Abstract

19. Salib E, Derienzo V, Wiegand T. Unintentional Pediatric Opioid Exposures Reported to the ToxIC Case Registry. Clin Toxicol. 2015 53(7):741. View Abstract

20. Spyres MB, Ruha M, Wax P. Clinical and Demographic Factors in Marijuana Toxicity: The ToxIC Registry Experience since 2010.  Clin Toxicol. 2015 53(7):677. View Abstract

21. Stephani JA, Hendrickson RG. Single-Drug Exposures Associated with Rhabdomyolysis – A Review of the ToxIC Registry. J Med Toxicol. 2015 March, 11;41. View Abstract

22. Varney SM, Wiegand TJ, Ramos RG, Brent J, Wax PM. A Descriptive Study of Prescription Opioid Misusers Evaluated by Medical Toxicologists.  J Med Toxicol. 2015 March, 11;44. View Abstract

23. Wang GS, Levitan R, Wiegand T, Lowry J, Schult R, Yin S. Extracorporeal Membrane Oxygenation for Severe Toxicologic Exposures: Review of the Toxicology Investigators Consortium (ToxIC).  J Med Toxicol. 2015 March, 11;45. View Abstract

24. Wax PM, Brent J, Campleman S. The Use of Insulin-Euglycemic Therapy by Medical Toxicologists.  J Med Toxicol. 2015 March, 11;45. View Abstract

25. Wiegand TJ, Abar B, Derienzo V, Botelho S, Conner K. Intentional Pharmaceutical Overdoses: Comparison of Self-harm, Misuse/abuse and Therapeutic Misadventure ToxIC Case Registry Entries. J Med Toxicol. 2015 March, 11;46. View Abstract

2014

1. Ahari S, O’Geen, R, Wiegand, TJ. Use of Multidose Activated Charcoal in the ToxIC Registry. J Med Toxicol. 2014;10:71. View Abstract

2. Cao JD, Bronstein AC, Lavonas EJ. Comparative analysis of exposure substances in the Toxicology Investigators Consortium case registry versus National Poison Data System. Clin Toxicol. 2014;52:783. View Abstract

3. Carey JL, Boyle KL, Rhyee S. Gender Differences In Prescription Medication Abuse. Acad Emerg Med. 2014. View Abstract

4. Farmer BM, Nelson LS, Perrone J. Bedside Evaluation of Adverse Drug Events by Medical Toxicologists. J Med Toxicol. 2014;10:78-79. View Abstract

5. Farrugia LA, Rhyee SH. Characteristics of Patients Presenting to a Medical Toxicologist for Exposure to Heavy Metals. J Med Toxicol. 2014;10:79. View Abstract

6. Fil LF, Nelson LN , Olsen D. Naloxone Administration in the Pediatric Population According to ToxIC Database Reporting. J Med Toxicol. 2014;10:80. View Abstract

7. Finkelstein Y, Zelner I, Hutson JR, Matlow J, Koren G, Wax PM. Poisoning During Pregnancy: Observations from the Toxicology Investigators Consortium (ToxIC) Case Registry. J Med Toxicol. 2014;10:80. View Abstract

8. Hendrickson RG. Medications that are associated with serotonin toxicity: A review of the ToxIC Registry. Clin Toxicol 2012;50(7):675. View Abstract

9. Hoyte C, Brent J. A characterization of cases of severe hyperthermia reported to the ToxIC Registry. Clin Toxicol. 2014;52:692. View Abstract

10. Kopec KT, Vohra R, Brusin K, Santos J, Otong R, Smith E, Brent J, Wax PM. The ToxIC International Registry: Initial Glimpses from Medical Toxicology Consultation Services in Russia, Thailand, and Mexico. J Med Toxicol. 2014;10:84-85. View Abstract

11. Laes J. Characterizing flumazenil use through utilization of a toxicology registry. Clin Toxicol. 2014;52:761-762. View Abstract

12. Levine M, Iwanicki J, Leikin JB, Donovan JW, McKay CA, Hernandez S, et al., for the Management with Intravenous Lipid in Overdose (MILO) investigators. Intravenous Lipid Emulsion Therapy use in the Toxicology Investigators Consortium (ToxIC). J Med Toxicol. 2014;10:85. View Abstract

13. McKeever, RG Sexton KJ, Vearrier D, Greenberg MI. Characteristics of salicylate ingestions reported to the toxic registry. Clin Toxicol. 2014;52:808. View Abstract

14. Onisko NS, Wax PM , Kleinschmidt KC. Non-APAP Containing Xenobiotics Associated with AST >1,000 U/L. J Med Toxicol. 2014;10:89. View Abstract

15. Ordonez J, Forrester MB, Wax PM, Kleinschmidt KC. A Comparative Study of Acetaminophen Exposures in ToxIC Registry with Texas Poison Center Data. J Med Toxicol. 2014;10:90. View Abstract

16. Ruha AM, Levitan R, Kleinschmidt KC, Vohra R, Smith E, Brent J, Wax PM. The ToxIC North American Snakebite Registry. J Med Toxicol. 2014;10:91. View Abstract

17. Troncoso A, Calello D. Pediatric laundry detergent pod exposures: Report from the Toxicology Investigator ’s Consortium (ToxIC registry). Clin Toxicol. 2014;52:723. View Abstract

18. Watkins JW, Schwarz E, Arroyo-Plasencia A, Mullins M. The differential use of physostigmine by toxicologists in anticholinergic toxicity based on causative agent. Clin Toxicol. 2014;52:753-754. View Abstract

19. Watkins JW, Schwarz EA, Arroyo-Plasencia AM. The Use of Physostigmine by Toxicologists in Anticholinergic Toxicity. J Med Toxicol. 2014;10:70. View Abstract

2013

1. Hoyte C, Brent J. Cases of QT interval prolongation reported to the ToxIC (Toxicology Investigators Consortium) Registry. Clin Toxicol. 2013;51:656. View Abstract

2. Kopec K, Vohra R, Brusin K, Smith EA, Brent J, Wax P. Development of an international registry of poisoned patients using toxic. Clin Toxicol. 2013;51:631. View Abstract

3. Ordonez J, Kleinschmidt K, Wax P. Non-Ethanol hyperlipasemia in toxicology consultation. Clin Toxicol. 2013;51:703. View Abstract

4. Schwartz T, Wax P, Wiegand T. The use of hemodialysis in medical toxicology practice: The toxic experience. Clin Toxicol. 2013;51:613. View Abstract

2012

1. Finkelstein Y, Hutson JR, Brent J, Wax PM. Drug-induced seizures in children presenting to the emergency department. Clin Toxicol. 2012;50:676. View Abstract

2. Hendrickson R, Witte D. Serotonin toxicity: Case characteristics and associated medications/drugs. Clin Toxicol. 2012;50:675. View Abstract

3. Obafemi AI, Wax P, Kleinschmidt K. Chelation therapy by medical toxicologists in the U.S. Clin Toxicol. 2012;50:664. View Abstract

4. Schwarz ES, Wax PM. Medical toxicology referrals in the acute care setting. Clin Toxicol. 2012;50;674. View Abstract

5. Vohra R,Kopec K, Brent J, Wax P, Gunja N. Pesticide poisonings reported to the ACMT Toxicology Investigators Consortium (ToxIC) Registry. APAMT Annual Meeting Proceedings. 2012. View Abstract

6. Zosel A, Ludtke H, Dille KS, Ippen C, Brent J. Characterizing herbals and dietary supplements toxicities using the Toxicology InvestigatorsConsortium (ToxIC) registry. Clin Toxicol. 2012;50:659. View Abstract

2011

1. Kleinschmidt K, Wax P, Brent J. Comparison of Data in the Toxicology Investigators Consortium (ToxIC) Registry with the National Poison Data System (NPDS). Clin Toxicol. 2011;49:593. View Abstract

2. McKay C, Hart K. Hyperkalemia Does Not Predict Outcome From Digoxin Excess in Patients With Renal Dysfunction. Clin Toxicol. 2011;49:560. View Abstract

3. Smolcic E, Sachdeva K, Cresswell A, Donovan W, Rasimas J. Themes and Trends in Serious Intentional Self-Poisoning. Clin Toxicol. 2011;49:571. View Abstract

4. Wax P, Brent J. The Toxicology Investigators Consortium (ToxIC ) Registry: A National Registry of Patients Seen by Medical Toxicologists at the Bedside. EAPCCT Annual Meeting Proceedings. 2011. View Abstract

5. Wax P. Toxicology Investigator’s Consortium (ToxIC): Overview and Next Steps. J Med Toxicol. 2011;7:70. View Abstract

6. Wiegand T, Kamali M, Barton N, Wax P.  Alcohol intoxication, co-ingestion and withdrawal in Medical Toxicology consultations: a review of the ToxIC Case Registry. Clin Toxicol. 2011;49;531. View Abstract

2010

1. Kleinschmidt K, Wax P, Nelson L, Bird S, Brent J. The Toxicology Investigators Consortium (ToxIC) Registry – Establishing Its Viability. Clin Toxicol. 2010;48:651. View Abstract

2. Sharma K, Nelson L, Kurt K, Bird S, Brent J, Wax P. The Practice of Medical Toxicology in the US. Clin Toxicol. 2010;48:666-667. View Abstract

2009

1. Wax PM, Brent J. The Current Status of the Practice of Inpatient Medical Toxicology at the Bedside in the US. Clin Toxicol. 2009;47:470. View Abstract